Gene · 407017
Papers3,057
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,057
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer. | Breast Cancer Res Treat | 2023 | 37540289 | PubTator, text mining | PubMed |
| Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence. | Cancer Biol Ther | 2023 | 37526431 | PubTator, text mining | PubMed |
| MicroRNA targeting: A novel therapeutic intervention for ovarian cancer. | Biochem Biophys Rep | 2023 | 37521375 | PubTator, text mining | PubMed |
| Progress of regulatory RNA in small extracellular vesicles in colorectal cancer. | Front Cell Dev Biol | 2023 | 37519298 | PubTator, text mining | PubMed |
| MicroRNAs-Based Theranostics against Anesthetic-Induced Neurotoxicity. | Pharmaceutics | 2023 | 37514018 | PubTator, text mining | PubMed |
| Capturing the Kidney Transcriptome by Urinary Extracellular Vesicles-From Pre-Analytical Obstacles to Biomarker Research. | Genes (Basel) | 2023 | 37510317 | PubTator, text mining | PubMed |
| From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA Signatures. | Diagnostics (Basel) | 2023 | 37510186 | PubTator, text mining | PubMed |
| MicroRNAs in Juvenile Idiopathic Arthritis: State of the Art and Future Perspectives. | Biology (Basel) | 2023 | 37508421 | PubTator, text mining | PubMed |
| Pathology and Molecular Biology of Melanoma. | Curr Issues Mol Biol | 2023 | 37504268 | PubTator, text mining | PubMed |
| Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort. | Sci Rep | 2023 | 37491482 | PubTator, text mining | PubMed |
| Transcriptional repression of lncRNA and miRNA subsets mediated by LRF during erythropoiesis. | J Mol Med (Berl) | 2023 | 37486375 | PubTator, text mining | PubMed |
| The secretome as a biomarker and functional agent in heart failure. | J Cardiovasc Aging | 2023 | 37484982 | PubTator, text mining | PubMed |
| Upregulation and the clinical significance of KCNQ1OT1 and HAGLROS lncRNAs in papillary thyroid cancer: An observational study. | Medicine (Baltimore) | 2023 | 37478216 | PubTator, text mining | PubMed |
| Immune function of colon cancer associated miRNA and target genes. | Front Immunol | 2023 | 37465677 | PubTator, text mining | PubMed |
| MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p. | J Bone Oncol | 2023 | 37457846 | PubTator, text mining | PubMed |
| Role of salivary miRNAs in the diagnosis of gastrointestinal disorders: a mini-review of available evidence. | Front Genet | 2023 | 37456668 | PubTator, text mining | PubMed |
| Paper-based biosensors as point-of-care diagnostic devices for the detection of cancers: a review of innovative techniques and clinical applications. | Front Oncol | 2023 | 37456253 | PubTator, text mining | PubMed |
| Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer. | Front Oncol | 2023 | 37456240 | PubTator, text mining | PubMed |
| The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review. | Int J Mol Sci | 2023 | 37446128 | PubTator, text mining | PubMed |
| Small RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Study. | Int J Mol Sci | 2023 | 37445821 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407017/papers?page=12